Ion Endoluminal System

Intuitive Surgical's Ion Endoluminal System is a robotic-assisted bronchoscopy platform for minimally invasive biopsy of peripheral lung nodules. It uses an ultra-thin, shape-sensing maneuverable catheter with PlanPoint CT-based airway planning to reach lesions deep in the peripheral lung. FDA 510(k) cleared in February 2019 and commercially deployed across US hospitals, with subsequent AI and advanced-imaging integration clearances.

Yes. Ion Endoluminal System is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.

Ion Endoluminal System is made by Intuitive Surgical, based in Sunnyvale, California, USA, founded in 1995.

1 verified deployment of Ion Endoluminal System is on the DEPLOY registry, including at United States.

Ion Endoluminal System is in commercial deployment and is sold to operators; contact the manufacturer to buy, and see the pricing section for any recorded price.

Ion Endoluminal System has 5 regulatory records on the DEPLOY registry: FDA recall (Z-1134-2026), recalled; FDA recall (Z-2720-2024), recalled; FDA recall (Z-0106-2022), recalled and 2 more. See the Regulatory filings section for each agency source.

On the DEPLOY registry, comparable surgical robots to Ion Endoluminal System include da Vinci (and Ion), Edge Multi-Port Surgical Robot, Edison Histotripsy System, Stryker Mako SmartRobotics.

Ion Endoluminal System and da Vinci (and Ion) (Intuitive Surgical · 15 deployments) are both surgical robots on the DEPLOY registry. Ion Endoluminal System has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.

On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Ion Endoluminal System ranks in roughly the top 82% of surgical models tracked by the registry.

Ion Endoluminal System is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Ion Endoluminal System has 5 active incidents on record in the DEPLOY registry. 3 recalls and 2 incidents on record (5 serious). Most recent: Apr 2026. Retracted incidents are excluded from this count.